| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |